Regulation of the P2X7R by microRNA-216b in human breast cancer
- PMID: 25078617
- DOI: 10.1016/j.bbrc.2014.07.101
Regulation of the P2X7R by microRNA-216b in human breast cancer
Abstract
Breast cancer is the most common cancer in women around the world. However, the molecular mechanisms underlying breast cancer pathogenesis are only partially understood. Here, in this study, we found that P2X7R was up-regulated and miR-216b was down-regulated in breast cancer cell lines and tissues. Using bioinformatic analysis and 3'UTR luciferase reporter assay, we determined P2X7R can be directly targeted by miR-216b, which can down-regulate endogenous P2X7R mRNA and protein levels. Ectopic expression of miR-216b mimics leads to inhibited cell growth and apoptosis, while blocking expression of the miR-216b results in increased cell proliferation. Furthermore, our findings demonstrate that knockdown of P2X7R promotes apoptosis in breast cancer cells through down-regulating Bcl-2 and increasing the cleavage caspase-3 protein level. Finally, we confirmed that down-regulation of miR-216b in breast cancer is inversely associated with P2X7R expression level. Together, these findings establish miR-216b as a novel regulator of P2X7R and a potential therapeutic target for breast cancer.
Keywords: Apoptosis; Bcl-2; Breast cancer; Caspase-3; P2X7R; miR-216b.
Copyright © 2014. Published by Elsevier Inc.
Similar articles
-
MicroRNA: Crucial modulator in purinergic signalling involved diseases.Purinergic Signal. 2023 Mar;19(1):329-341. doi: 10.1007/s11302-022-09840-y. Epub 2022 Feb 2. Purinergic Signal. 2023. PMID: 35106737 Free PMC article. Review.
-
MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.Life Sci. 2019 Nov 15;237:116945. doi: 10.1016/j.lfs.2019.116945. Epub 2019 Oct 9. Life Sci. 2019. PMID: 31605710
-
miR-216b suppresses breast cancer growth and metastasis by targeting SDCBP.Biochem Biophys Res Commun. 2017 Jan 1;482(1):126-133. doi: 10.1016/j.bbrc.2016.10.003. Epub 2016 Oct 5. Biochem Biophys Res Commun. 2017. PMID: 27720715
-
MiR-1228 promotes breast cancer cell growth and metastasis through targeting SCAI protein.Int J Clin Exp Pathol. 2015 Jun 1;8(6):6646-55. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261546 Free PMC article.
-
[miR-216b suppresses cell proliferation and invasion by targeting PKCα in nasopharyngeal carcinoma cells].Zhonghua Zhong Liu Za Zhi. 2013 Sep;35(9):645-50. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 24332049 Chinese.
Cited by
-
Functional role of P2X7 purinergic receptor in cancer and cancer-related pain.Purinergic Signal. 2024 May 21. doi: 10.1007/s11302-024-10019-w. Online ahead of print. Purinergic Signal. 2024. PMID: 38771429 Review.
-
Elucidating the molecular basis of ATP-induced cell death in breast cancer: Construction of a robust prognostic model.World J Clin Oncol. 2024 Feb 24;15(2):208-242. doi: 10.5306/wjco.v15.i2.208. World J Clin Oncol. 2024. PMID: 38455130 Free PMC article.
-
Notopterol Ameliorates Hyperuricemia-Induced Cardiac Dysfunction in Mice.Pharmaceuticals (Basel). 2023 Feb 27;16(3):361. doi: 10.3390/ph16030361. Pharmaceuticals (Basel). 2023. PMID: 36986461 Free PMC article.
-
ATP-gated P2X7 receptor as a potential target for prostate cancer.Hum Cell. 2022 Sep;35(5):1346-1354. doi: 10.1007/s13577-022-00729-x. Epub 2022 Jun 3. Hum Cell. 2022. PMID: 35657562 Review.
-
P2X7 receptor involved in antitumor activity of atractylenolide I in human cervical cancer cells.Purinergic Signal. 2023 Mar;19(1):145-153. doi: 10.1007/s11302-022-09854-6. Epub 2022 Mar 2. Purinergic Signal. 2023. PMID: 35235139 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
